期刊文献+

动态血压监测比较贝尼地平片与硝苯地平控释片的临床疗效 被引量:1

Comparison of Benidipine to Nifediping controlled released tablets in the treatment of hypertension by ambulatory blood pressure monitoring
下载PDF
导出
摘要 目的应用动态血压监测(ABPM)的方法,评价盐酸贝尼地平和硝苯地平控释片对轻、中度高血压病的疗效。方法选择原发性高血压患者118例随机分为盐酸贝尼地平组(n=56)和硝苯地平控释片组(n=62),分别给与盐酸贝尼地平、硝苯地平控释片治疗,疗程为8周,并于治疗前后进行动态血压监测(ABPM)。结果两药均能降低24h、白昼、夜间血压,但差异无统计学意义,仅硝苯地平控释片全日平均收缩压下降有统计学差异(P<0.05)。硝苯地平控释片组服药后24h舒张压的平滑指数(24hSID)、白天收缩压的平滑指数(dSIS)、夜间舒张压的平滑指数(nSID)较服药前有明显降低(P<0.05),贝尼地平组服药后24hSID、nSID较服药前有明显降低(P<0.05),同时硝苯地平控释片组服药后24h收缩压的平滑指数(24SID)、夜间收缩压的平滑指数(nSID)均较贝尼地平组明显降低(P<0.01)。硝苯地平控释片组、贝尼地平组的收缩压晨峰服药后均较服药前减低(P<0.05),硝苯地平控释片组舒张压晨峰服药后较服药前减低(P<0.05),但两组间比较,差异无显著性。两药均无明显不良反应发生。结论盐酸贝尼地平和硝苯地平控释片一样的能安全有效的降压。两者均能有效控制晨峰,具有满意的平滑指数。 【Objective】To assess the antihypertensionsive effect of Benidipine and Nifediping controlled released tablet in patients with essential hypertension by ambulatory blood pressure monitoring (ABPM).【Methods】118 pa-tients with essential hypertension were enrolled and arranged randomly to two groups.They were treated with Beni-dipine (n =56) or Nifediping controlled released tablets (n =62) respectively for 8 weeks and visited every two weeks.ABPM and biochemical examination were performed before and after drug...
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2008年第22期3365-3368,共4页 China Journal of Modern Medicine
关键词 贝尼地平 硝苯地平控释片 高血压 晨峰 动态血压监测 Benidipine Nifediping controlled released tablet hypertension morning blood pressure surge am-bulatory blood pressure monitoring
  • 相关文献

参考文献3

二级参考文献31

  • 1施仲伟.血压变异性:临床意义和抗高血压治疗的作用[J].国外医学(心血管疾病分册),1995,22(4):227-228. 被引量:33
  • 2何汝敏.昼夜节律和血压控制:生理和病理生理因素[J].国外医学(心血管疾病分册),1995,22(5):277-279. 被引量:14
  • 3Song YM, Sung J, Lawlor DA, Smith DG, Shin Y, Ebrahim S.Blood pressure, haemorrhagic stroke, and ischaemic stroke : the Korean national prospective occupational cohort study [J]. BMJ, 2004 ;328(7435): 324-325.
  • 4He J, Whelton PK. Elevated systolic blood pressure and risk of cardiovascular and renal disease: overview of evidence from observational epidemiologic studies and randomized controlled trials[J ]. Am Heart J, 1999; 138(3 Pt2): 211 -219.
  • 5Luscher TF, Cosentino F. The classification of calcium antagonists and their selection in the treatment of hypertension, A reappraisal[J].Drugs, 1998; 55(4): 509-517.
  • 6Asmar R, Benetos A, Ghodsi N, Meilhac B, Safar M. Regional arterial hemodynamics and carotid circulation in essential arterial hypertension. Effect of nitrendipine in patients over 40 years of age[J].Presse Medicale, 1993 ; 22(35) : 1770 - 1775.
  • 7Zanchetti A, Bond MG, Hennig M, Neiss A, Mancia G, Dal Palu C, et al. European Lacidipine Study on Atherosclerosis investigators.Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind,long-term trial[J ]. Circulation, 2002 ; 106 ( 19 ) : 2422 - 2427.
  • 8Simon A, Gariepy J, Moyse D, Levenson J. Differential effects of nifedipine and co-amilozide on the progression of early carotid wall changes[J ]. Circulation, 2001 ; 103 (24) : 2949 - 2954.
  • 9Neal B, MacMahon S, Chapman N. Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews ofrandomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration [ J ]. Lancet, 2000; 356(9246) : 1955 - 1964.
  • 10Kaplan NM. Hypertension trials: 1990 to 2000[J]. Current Opinion in Nephrology & Hypertension, 2001 ; 10 ( 4 ) : 501 - 505.

共引文献36

同被引文献7

引证文献1

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部